BioCryst Pharmaceuticals, Inc. (BCRX) has a market capitalization of $2.03B and trades at $9.67. The 52-week range is 6-11.31.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 7.7, Earnings Per Share (EPS) of $1.26, annual revenue of $874.84M.
The stock has a beta of 0.69, operates in the Healthcare sector.
